Cyclacel Pharmaceuticals (CYCC) Stock Chart & Stock Price History $0.36 +0.04 (+13.75%) Closing price 06/12/2025 04:00 PM EasternExtended Trading$0.34 -0.02 (-4.74%) As of 08:14 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cyclacel Pharmaceuticals Stock Price Performance The Cyclacel Pharmaceuticals (CYCC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 98.64%, with a year-to-date return of -94.03%. In the past month, the stock has decreased 86.95%, reflecting recent market activity. As of the latest close, Cyclacel Pharmaceuticals traded at $0.36 with a market cap of $8.06 million and volume of 4.16 million shares. Five years ago, the stock traded at a split-adjusted price of $1,082.40, representing a 99.97% decrease over that period. At the time, it had a market cap of $24.15 million and a volume of 879 shares. Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.97%1 Month Performance-86.95%3 Month Performance-92.61%Year-To-Date Performance-94.03%1 Year Performance-98.64%5 Year Performance-99.97% CYCC Stock Chart for Friday, June, 13, 2025 CYCC Chart by TradingView Cyclacel Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/12/2025$0.32$0.36+13.75%$0.36$0.314.16 million shs$8.06 million06/11/2025$0.28$0.32+13.20%$0.38$0.279.02 million shs$7.09 million06/10/2025$0.34$0.28-19.14%$0.34$0.257.40 million shs$4.29 million06/09/2025$0.37$0.34-6.81%$0.41$0.296.64 million shs$5.31 million06/06/2025$0.61$0.37-38.84%$0.66$0.357.44 million shs$5.70 million06/05/2025$1.45$0.61-58.28%$1.55$0.585.55 million shs$9.32 million06/04/2025$1.67$1.45-13.17%$1.73$1.35587,810 shs$22.33 million06/03/2025$1.64$1.67+1.83%$1.72$1.5990,692 shs$25.71 million06/02/2025$1.65$1.64-0.55%$1.74$1.6064,105 shs$25.25 million05/30/2025$1.60$1.65+3.06%$1.82$1.56229,083 shs$25.39 million Get the Latest News and Ratings for CYCC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/29/2025$1.75$1.60-8.57%$1.76$1.56289,165 shs$24.64 million05/28/2025$1.62$1.75+8.02%$1.94$1.58276,111 shs$26.95 million05/27/2025$1.45$1.62+11.72%$1.68$1.44112,050 shs$24.94 million05/26/2025$1.45$1.45$1.56$1.36146,170 shs$22.33 million05/23/2025$1.46$1.45-0.68%$1.56$1.36146,170 shs$22.33 million05/22/2025$1.57$1.46-7.01%$1.60$1.43200,307 shs$22.48 million05/21/2025$1.75$1.57-10.29%$1.87$1.53278,830 shs$20.35 million05/20/2025$2.00$1.75-12.50%$2.15$1.67237,019 shs$22.68 million05/19/2025$2.00$2.00$2.05$1.90157,755 shs$25.92 million05/16/2025$2.20$2.00-9.09%$2.31$1.95144,475 shs$414.67 million05/15/2025$2.32$2.20-5.17%$2.50$2.15180,474 shs$456.14 million05/14/2025$2.75$2.32-15.64%$2.77$2.21252,119 shs$481.02 million05/13/2025$3.59$2.75-23.40%$3.93$2.69325,659 shs$570.17 million05/12/2025$0.25$3.59+1,312.83%$4.61$3.52160,429 shs$744.34 million Related Companies Virios Therapeutics Stock Chart Adagene Stock Chart Oramed Pharmaceuticals Stock Chart OptiNose Stock Chart HilleVax Stock Chart C4 Therapeutics Stock Chart Anixa Biosciences Stock Chart Coya Therapeutics Stock Chart Milestone Pharmaceuticals Stock Chart Genelux Stock Chart Receive CYCC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cyclacel Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CYCC) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredBanks aren’t ready for this altcoin—are you?Donald Trump just fast-tracked TWO major crypto bills with an August deadline! Your window of opportunity i...Crypto 101 Media | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cyclacel Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cyclacel Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
